Dopamine Agonists (administration & dosage) < Dopamine Agonists (adverse effects) < Dopamine Agonists (blood)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000024 (1999)	N. Vaserman-Lehuédé [France] ; M. Vérin	Shoulder pain in patients with Parkinson's disease.
000042 (1999)	C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol	Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000199 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
000271 (2002)	C. Lebrun-Frenay [France] ; M. Borg	Choosing the right dopamine agonist for patients with Parkinson's disease.
000347 (2003)	Olivier Rascol [France]	Monoamine oxidase inhibitors--is it time to up the TEMPO?
000406 (2003)	N V Fedorova	[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
000517 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000523 (2005)	Isabelle Arnulf [France]	Excessive daytime sleepiness in parkinsonism.
000627 (????)	Jean-Louis Montastruc [France] ; Agnès Sommet ; Pascale Olivier ; Haleh Bagheri ; Mireille Gony ; Maryse Lapeyre-Mestre ; Christine Brefel-Courbon ; Joachim Ferreira ; Laurent Schmitt ; Jean-Michel Senard ; Olivier Rascol	[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance].
000649 (2006)	Dominique Drapier [France] ; Sophie Drapier ; Paul Sauleau ; Pascal Derkinderen ; Philippe Damier ; Herve Allain ; Marc Vérin ; Bruno Millet	Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
000864 (2008)		Rotigotine: Parkinson's disease: a step backward.
000870 (2008)	D. Dupuy [France] ; J P Lesbre ; P. Gérard ; M. Andrejak ; O. Godefroy	Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications.
000973 (2009)	Olivier Rascol [France] ; Santiago Perez-Lloret	Rotigotine transdermal delivery for the treatment of Parkinson's disease.
000B35 (2010)	Stéphane Thobois [France] ; Claire Ardouin ; Eugénie Lhommée ; Hélène Klinger ; Christelle Lagrange ; Jing Xie ; Valérie Fraix ; Maria Clara Coelho Braga ; Rachid Hassani ; Andrea Kistner ; Alexandra Juphard ; Eric Seigneuret ; Stephan Chabardes ; Patrick Mertens ; Gustavo Polo ; Anthonin Reilhac ; Nicolas Costes ; Didier Lebars ; Marc Savasta ; Léon Tremblay ; Jean-Louis Quesada ; Jean-Luc Bosson ; Alim-Louis Benabid ; Emmanuel Broussolle ; Pierre Pollak ; Paul Krack	Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
000C28 (2010)	Santiago Perez-Lloret [France] ; Olivier Rascol	Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
000C73 (2011)	O. Rascol [France]	Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
000E18 (2012)	N. Carrière [France] ; A. Kreisler ; K. Dujardin ; A. Destée ; L. Defebvre	[Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
000E50 (2013)	Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Pietro Lucca Ratti ; Olivier Rascol	Rotigotine transdermal patch for the treatment of Parkinson's Disease.
000F84 (2013)	Anna Castrioto [France] ; Andrea Kistner ; Hélène Klinger ; Eugénie Lhommée ; Emmanuelle Schmitt ; Valérie Fraix ; Stephan Chabardès ; Patrick Mertens ; Jean-Louis Quesada ; Emmanuel Broussolle ; Pierre Pollak ; Stéphane C. Thobois ; Paul Krack	Psychostimulant effect of levodopa: reversing sensitisation is possible.
001008 (????)	Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Christine Brefel-Courbon ; Jean-Louis Montastruc ; Olivier Rascol	Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
001075 (2013)	W M M. Schuepbach [France] ; J. Rau ; K. Knudsen ; J. Volkmann ; P. Krack ; L. Timmermann ; T D H Lbig ; H. Hesekamp ; S M Navarro ; N. Meier ; D. Falk ; M. Mehdorn ; S. Paschen ; M. Maarouf ; M T Barbe ; G R Fink ; A. Kupsch ; D. Gruber ; G-H Schneider ; E. Seigneuret ; A. Kistner ; P. Chaynes ; F. Ory-Magne ; C. Brefel Courbon ; J. Vesper ; A. Schnitzler ; L. Wojtecki ; J-L Houeto ; B. Bataille ; D. Maltête ; P. Damier ; S. Raoul ; F. Sixel-Doering ; D. Hellwig ; A. Gharabaghi ; R. Krüger ; M O Pinsker ; F. Amtage ; J-M Régis ; T. Witjas ; S. Thobois ; P. Mertens ; M. Kloss ; A. Hartmann ; W H Oertel ; B. Post ; H. Speelman ; Yves Agid [France] ; C. Schade-Brittinger ; G. Deuschl	Neurostimulation for Parkinson's disease with early motor complications.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dopamine Agonists (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dopamine Agonists (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agonists (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024